Hallie Kuhn
Vice President @ Alexandria Real Estate Equities
Pasadena, United States
Hallie Kuhn is a Series A investor at Alexandria Real Estate Equities in Pasadena focused on Life Science and Biotechnology. Hallie Kuhn, Ph.D. is Vice President, Science & Technology, at Alexandria Real Estate Equities, Inc. and its corporate venture arm, Alexandria Venture Investments. In her role, Dr. Kuhn oversees strategic venture investments across Southern California, with a portfolio of over 25 life science investments. She also works closely withAlexandria’s real estate development team to support business development and tenant underwriting in San Diego and Greater LA.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Hallie Kuhn invests in
Stages Hallie Kuhn invests in
Countries Hallie Kuhn invests in
Investment Focus
Industry
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Eclipse Bioinnovations
|
Eclipse Bioinnovations is a leading RNA genomics company founded in 2017 based on technology developed at the University of California, San Diego. Eclipse's mission is to use their pioneering RNA genomics platform technologies to advance RNA medicines and scientific discovery. Eclipse’s founders developed eCLIP, the world’s most efficient andunique CLIP-seq technology for identifying RNA binding protein gene partners and gene maps. Eclipse’s suite of RNA genomics technologies now cover eCLIP-RBP for mapping the RNA binding proteins, miR-eCLIP for the miR-interactome, m6A-eCLIP for RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for simplifying Crispr library prep. Products are offered as services and kit for biopharma companies and academic researchers, and can be customized for clients. | $14M / Series A / Mar 15, 2022 |
Co-Investors
Phoenix Venture Partners
1 deal together
About Alexandria Real Estate Equities
Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest owner and pre-eminent first-in-class real estate investment trust focused principally on science-driven cluster formation. Alexandria is the leading provider of real estate to the life science industry, and has an outstanding 11 year trackrecord as a NYSE listed company with an approximate $5.2 billion total market capitalization (as of December 31, 2008).
Alexandria Real Estate Equities Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John J. Cox
Senior Vice President
|
|||
Steven Hash
Board of Director
|
|||
Daniel J. Ryan
Executive Vice President
|
|||
|
Hallie Kuhn
Vice President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hallie Kuhn invest in?
Hallie Kuhn invests primarily in Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hallie Kuhn last invest?
The most recent investment recorded for Hallie Kuhn closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
